9:22 AM
Leo Group India
| ||
| ||
| Surya Pharmaceutical Limited Moneycontrol.com Surya Pharmaceutical Limited. Alka Goyal has submitted to the Exchange, vide letter dated August 06, 2012 a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. See all stories on this topic » | ||
| Thousands detained in China fake pharmaceuticals raid ABC Online Police in China have detained almost 2000 people during a national blitz on fake pharmaceutical drugs. The public security ministry says more than 180 million dollars worth of counterfeit products have been seized, and 1100 production facilities have been ... See all stories on this topic » | ||
| UN says Syria fighting causing pharmaceutical plants there to stop work, causing ... Montreal Gazette GENEVA - The World Health Organization says fighting in Syria has caused many of the country's pharmaceutical plants to stop working, causing shortages of medicines. WHO spokesman Tarik Jasarevic says 90 per cent of the plants are in Aleppo, Homs ... See all stories on this topic » | ||
| Sale talk for Douglas Pharmaceuticals The Australian According to sources, an information memorandum has been circulated to prospective buyers. Auckland-based Douglas Pharmaceuticals was founded in 1967 and exports products to European, North America, the Middle East and Asia-Pacific. The company ... See all stories on this topic » | ||
| Cadence Pharmaceuticals' Ofirmev Launch Has Gained Traction: Buy Seeking Alpha I am reiterating my buy recommendation on Cadence Pharmaceuticals . As a small, emerging company almost all of the investment focus on has been on its lead product. Ofirmev. Like all new products, investors go through a checklist to try to determine ... See all stories on this topic » | ||
| RIGEL PHARMACEUTICALS, INC. : Rigel Announces Second Quarter 2012 ... 4-traders 7, 2012 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the second quarter and six months ended June 30, 2012. (Logo: http://photos.prnewswire.com/prnh/20030226/RIGLLOGO). For the second quarter of 2012 ... See all stories on this topic » | ||
| INFINITY PHARMACEUTICALS INC. : Infinity Reports Second Quarter 2012 ... 4-traders Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today highlighted its recent clinical and business progress and reported its financial results for the second quarter of 2012. "Our business has evolved substantially this year. We've made strong progress with ... See all stories on this topic » | ||
| Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory ... Equities.com 7, 2012 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (OTC Markets Group: IMMY), a specialty pharmaceutical company developing non-invasive, topically delivered products, announced that it has created a Science and Regulatory Advisory Board and that ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment